90 results on '"Lewis, Basil S."'
Search Results
2. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
3. Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
4. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial
5. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
6. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
7. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
8. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
9. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
10. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
11. Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST: Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento del síndrome coronario agudo (SCA) en pacientes sin elevación persistente del segmento ST
12. Guía ESC 2020 para el tratamiento de las cardiopatías congénitas del adulto
13. Automated Computer-Assisted Diagnosis of Obstructive Coronary Artery Disease in Emergency Department Patients Undergoing 256-Slice Coronary Computed Tomography Angiography for Acute Chest Pain
14. Low cardiorespiratory fitness and coronary artery calcification: Complementary cardiovascular risk predictors in asymptomatic type 2 diabetics
15. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial
16. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
17. Automatic Assessment of Coronary Artery Calcium Score from Contrast-Enhanced 256-Row Coronary Computed Tomography Angiography
18. Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial
19. Diagnostic Accuracy of 256-row Computed Tomographic Angiography for Detection of Obstructive Coronary Artery Disease Using Invasive Quantitative Coronary Angiography as Reference Standard
20. Absence of the α2c-Adrenoceptor Del322–325 Allele is Associated With Increased Mortality in Patients With Chronic Systolic Heart Failure
21. Stenting of the unprotected left main coronary artery in patients with severe aortic stenosis prior to percutaneous valve interventions
22. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
23. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
24. Pulse pressure and coronary atherosclerosis in asymptomatic type 2 diabetes mellitus: A 64 channel cardiac computed tomography analysis
25. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
26. Changes in the initial slope of the QRS in ischemic patients and normal subjects undergoing scintigraphy withdipyridamole
27. Cardiac computed tomographic angiography for risk stratification and prediction of late cardiovascular outcome events in patients with a chest pain syndrome
28. Coronary stent assessment on multidetector computed tomography: Source and predictors of image distortion
29. Aldosterone Synthase Gene Polymorphism as a Determinant of Atrial Fibrillation in Patients With Heart Failure
30. Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]
31. Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]
32. Percutaneous Coronary Intervention in Patients Receiving Enoxaparin or Unfractionated Heparin After Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction in the ExTRACT-TIMI 25 Trial
33. Impact of 64-Slice Cardiac Computed Tomographic Angiography on Clinical Decision-Making in Emergency Department Patients With Chest Pain of Possible Myocardial Ischemic Origin
34. Usefulness of 64-Slice Multidetector Computed Tomography in Diagnostic Triage of Patients With Chest Pain and Negative or Nondiagnostic Exercise Treadmill Test Result
35. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor
36. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
37. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients
38. Evaluation of the phase-plane ECG as a technique for detecting acute coronary occlusion
39. TAPERING AND DISCONTINUATION OF BACKGROUND THERAPIES DURING THE TRANSITION TO RILONACEPT MONOTHERAPY IN RHAPSODY, A PHASE 3 CLINICAL TRIAL OF RILONACEPT IN PATIENTS WITH RECURRENT PERICARDITIS
40. CARDIAC MAGNETIC RESONANCE IMAGING FOR GUIDING DECISION-MAKING ON TREATMENT DURATION: DATA FROM RHAPSODY, A PHASE 3 CLINICAL TRIAL OF RILONACEPT IN RECURRENT PERICARDITIS
41. Late-onset heart failure as a mechanism for adverse long-term outcome in diabetic patients undergoing revascularization (a 13-year report from the Lady Davis Carmel Medical Center Registry)
42. Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes
43. The use of exercise stress testing for the management of low-risk patients with chest pain
44. Possible contribution of pericardial tamponade to coronary artery bypass graft occlusion
45. Prolonged intravenous eptifibatide infusion for prevention of coronary stent thrombosis
46. Prevalence and Extent of Obstructive Coronary Artery Disease in Patients With Zero or Low Calcium Score Undergoing 64-Slice Cardiac Multidetector Computed Tomography for Evaluation of a Chest Pain Syndrome
47. Brachial Reactivity and Extent of Coronary Artery Disease in Patients With First ST-Elevation Acute Myocardial Infarction
48. Relation Between Obesity and Severity of Coronary Artery Disease in Patients Undergoing Coronary Angiography
49. Computer-assisted diagnosis of obstructive coronary atherosclerosis in patients undergoing 256-slice coronary computed tomography angiography: A comparison with invasive coronary angiography
50. Haptoglobin genotype does not predict extent of coronary artery calcification in a prospective cohort of patients with type 2 diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.